Reconstruction of Complicated Posterior Maxillary Bone Defects Using Recombinant Human Bone Morphogenetic Protein-2 with Hydroxyapatite and Fibrin Sealant

Jung Woo Nam

doi:10.32542/implantology.2024020

All Issue

2024 Vol.28, Issue 4 Preview Page Next Page

Clinical or Case Report

Reconstruction of Complicated Posterior Maxillary Bone Defects Using Recombinant Human Bone Morphogenetic Protein-2 with Hydroxyapatite and Fibrin Sealant

31 December 2024. pp. 193-199

PDF XML

Abstract

In cases of common alveolar bone deficiency in the posterior edentulous maxilla, dental implant treatment can proceed following the reconstruction of the defect through alveolar ridge augmentation and/or maxillary sinus floor augmentation, depending on the specific characteristics of the bone deficiency. However, reconstruction remains challenging in cases of extensive alveolar defects with large bone perforations. The author successfully managed these complicated posterior maxillary bone defects using recombinant human bone morphogenetic protein-2 with hydroxyapatite and fibrin sealant as carriers. This report presents two cases demonstrating the efficacy of this approach.

Keywords

alveolar ridge augmentation

bone morphogenetic protein

dental implant

fibrin sealant

hydroxyapatite

oroantral fistula

References

Keestra JA, Barry O, Jong L, Wahl G. Long-term effects of vertical bone augmentation: a systematic review. J Appl Oral Sci 2016;24:3-17.

10.1590/1678-77572015035727008252PMC4775004

Nam JW, Khureltogtokh S, Choi HM, Lee AR, Park YB, Kim HJ. Randomised controlled clinical trial of augmentation of the alveolar ridge using recombinant human bone morphogenetic protein 2 with hydroxyapatite and bovine-derived xenografts: comparison of changes in volume. Br J Oral Maxillofac Surg 2017;55:822-9.

10.1016/j.bjoms.2017.07.01728864147

Nam JW, Chee YD, Park YB. Sinus Floor Augmentation Using Recombinant Human Bone Morphogenetic Protein-2 With Hydroxyapatite: Volume Assessment. J Craniofac Surg 2020;31:912-5.

10.1097/SCS.000000000000625132068727

McKay WF, Peckham SM, Badura JM. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int Orthop 2007;31:729-34.

10.1007/s00264-007-0418-617639384PMC2266665

Nam JW, Kim HJ. Stepwise verification of bone regeneration using recombinant human bone morphogenetic protein-2 in rat fibula model. J Korean Assoc Oral Maxillofac Surg 2017;43:373-87.

10.5125/jkaoms.2017.43.6.37329333367PMC5756794

Herford AS, Boyne PJ. Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). J Oral Maxillofac Surg 2008;66:616-24.

10.1016/j.joms.2007.11.02118355584

Kelly MP, Vaughn OL, Anderson PA. Systematic Review and Meta-Analysis of Recombinant Human Bone Morphogenetic Protein-2 in Localized Alveolar Ridge and Maxillary Sinus Augmentation. J Oral Maxillofac Surg 2016;74:928-39.

10.1016/j.joms.2015.11.02726707429

Nam JW. Efficacy of hydroxyapatite and fibrin sealant as carriers for bone morphogenetic protein-2 in maxillary sinus floor augmentation: a retrospective study. Int J Oral Maxillofac Surg 2024;53:795-801.

10.1016/j.ijom.2024.04.00538653626

Han JJ, Moon JE, Lee EH, Yang HJ, Hwang SJ. Clinical and radiographic outcomes of dental implant after maxillary sinus floor augmentation with rhBMP-2/hydroxyapatite compared to deproteinized bovine bone. PLoS One 2022;17:e0273399.

10.1371/journal.pone.027339936007001PMC9409565

Yang HJ, Hwang SJ. Void space and long-term volumetric changes of maxillary sinus floor augmentation with comparison between hydroxyapatite soaked with bone morphogenetic protein 2 and anorganic bovine xenograft alone. J Craniomaxillofac Surg 2019;47:1626-32.

10.1016/j.jcms.2019.07.01631395420

Kim HJ, Chung JH, Shin SY, Shin SI, Kye SB, Kim NK, et al. Efficacy of rhBMP-2/Hydroxyapatite on Sinus Floor Augmentation: A Multicenter, Randomized Controlled Clinical Trial. J Dent Res 2015;94:158S-65S.

10.1177/002203451559457326185033

Triplett RG, Nevins M, Marx RE, Spagnoli DB, Oates TW, Moy PK, et al. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg 2009;67:1947-60.

10.1016/j.joms.2009.04.08519686934

Kim MS, Lee JS, Shin HK, Kim JS, Yun JH, Cho KS. Prospective randomized, controlled trial of sinus grafting using Escherichia-coli-produced rhBMP-2 with a biphasic calcium phosphate carrier compared to deproteinized bovine bone. Clin Oral Implants Res 2015;26:1361-8.

10.1111/clr.1247125186180

Haidar ZS, Hamdy RC, Tabrizian M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery. Biotechnol Lett 2009;31:1817-24.

10.1007/s10529-009-0099-x19690804

Mizushima Y, Ikoma T, Tanaka J, Hoshi K, Ishihara T, Ogawa Y, et al. Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs. J Control Release 2006;110:260-5.

10.1016/j.jconrel.2005.09.05116313993

Xie G, Sun J, Zhong G, Liu C, Wei J. Hydroxyapatite nanoparticles as a controlled-release carrier of BMP-2: absorption and release kinetics in vitro. J Mater Sci Mater Med 2010;21:1875-80.

10.1007/s10856-010-4038-020300953

Information

Publisher :The Korean Academy of Oral & Maxillofacial Implantology
Publisher(Ko) :대한구강악안면임플란트학회
Journal Title :Journal of implantology and applied sciences
Journal Title(Ko) :대한구강악안면임플란트학회지
Volume : 28
No :4
Pages :193-199
Received Date : 2024-11-18
Revised Date : 2024-12-07
Accepted Date : 2024-12-17
DOI :https://doi.org/10.32542/implantology.2024020

Journal of implantology and applied sciences ISSN:2765-7833(Print) 2765-7841(Online) 대한구강악안면임플란트학회지

All Issue